Journal of Probiotics & Health
Open Access

Department of Microbiology, East Carolina University, Greenville, North Carolina, USA

Publications

• Review Article   
  Probiotic Therapy as a Complementary Treatment for Patients with COVID-19 and Other Upper Respiratory Tract Infections
  Author(s): Connie L. Brenstuhl*
  
  This literature review is aimed at assessing and summarizing relationships between the state of the microbiome and susceptibility to respiratory tract infections including COVID-19. It explores using probiotic therapy for patients infected with COVID-19, to improve outcomes, lessen the severity of symptoms, or prevent infection entirely. The coronavirus COVID-19 is known scientifically as severe acute respiratory syndrome coronavirus-2. The virus's binding sites for cell entry, the angiotensin-converting enzyme-2, are found in high concentrations in both respiratory and gut tissues. Probiotics may inhibit angiotensin-converting enzyme-2 receptor activity, thereby blocking viral entry into the cell. COVID-19 infection with alpha and delta variants has manifested clinically both in severe respiratory and gastrointestinal symptoms. The impact on the host’s micr.. View More»
  DOI: 10.35248/2329-8901.22.10.269

  Abstract HTML PDF